Study of Acid Peel and Laser for the Treatment of Melasma

This study has been completed.

First Received on April 26, 2007. Last Updated on June 1, 2011 History of Changes

Sponsor:	Northwestern University
Information provided by:	Northwestern University
ClinicalTrials.gov Identifier:	NCT00467233

Purpose

The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.

Condition	Intervention
Melasma	Procedure: Laser Treatment Procedure: Acid Peel

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment
Official Title:	Study of Acid Peel and Laser for the Treatment of Melasma

Further study details as provided by Northwestern University:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	20
Study Start Date:	May 2007
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: 1 Laser Treatment	Procedure: Laser Treatment Laser treatment to half of the face at each study visit
Experimental: 2 Acid peel	Procedure: Acid Peel Acid peel to half of the face at each study visit

Detailed Description:

The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.

Eligibility

Criteria

Inclusion Criteria:

Diagnosis of melasma lesion measuring at least 4 square centimeters.
Age 18-75 years.
Good health.
Willingness and ability to understand and provide informed consent for participation in the study.
Ability to communicate with the investigator.
Must be willing to forgo other treatment options for melasma during the course of the study.

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00467233

Locations

United States, Illinois
Northwestern University Dermatology Department
Chicago, Illinois, United States, 60611

Sponsors and Collaborators

Northwestern University

Investigators

Principal Investigator:

Murad Alam, MD

Northwestern University

More Information

No publications provided

Responsible Party:	Northwestern University, Murad Alam, MD
ClinicalTrials.gov Identifier:	NCT00467233 History of Changes
Other Study ID Numbers:	MA-123456-DD
Study First Received:	April 26, 2007
Last Updated:	June 1, 2011
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Melanosis
Hyperpigmentation
Pigmentation Disorders
Skin Diseases

ClinicalTrials.gov processed this record on February 12, 2012